chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Dizziness, Fatigue, Headache, Nausea
Clinical narrative: DIZZINESS; FACE STARTED SWELLING FROM  EYELIDS AND LIPS.; TIREDNESS; HIGH FEVER; NAUSEA; HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced dizziness, face started swelling from eyelids and lips., tiredness, high fever, nausea, and headache.  Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 103 deg/s. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dizziness, and nausea, and the outcome of tiredness, high fever, headache and face started swelling from eyelids and lips. was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia, Swelling face
Clinical narrative: DIZZINESS; FACE STARTED SWELLING FROM  EYELIDS AND LIPS.; TIREDNESS; HIGH FEVER; NAUSEA; HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced dizziness, face started swelling from eyelids and lips., tiredness, high fever, nausea, and headache.  Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 103 deg/s. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dizziness, and nausea, and the outcome of tiredness, high fever, headache and face started swelling from eyelids and lips. was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: HALF DOSE ADMINISTERED; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported .The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested.  No concomitant medications were reported.  On 12-APR-2021, the subject experienced half dose administered.   The outcome of half dose administered was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Conjunctivitis, Feeling abnormal, Incoherent, Pruritus, Urticaria
Clinical narrative: PINK EYE; HIVES; ITCHED ALL OVER (ON HANDS, BACK AND LEGS); TERRIBLE FEELING; SLIGHTLY INCOHERENT; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 09-APR-2021, the subject experienced terrible feeling. On 09-APR-2021, the subject experienced slightly incoherent. On 11-APR-2021, the subject experienced itched all over (on hands, back and legs). On 11-APR-2021, the subject experienced hives. On 12-APR-2021, the subject experienced pink eye. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from itched all over (on hands, back and legs), and the outcome of terrible feeling, slightly incoherent, hives and pink eye was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Pain, Pain in extremity
Clinical narrative: ACHES; SORE ARM; SLIGHT CHILLS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On 10-APR-2021, the subject experienced aches. On 10-APR-2021, the subject experienced sore arm. On 10-APR-2021, the subject experienced slight chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the sore arm, slight chills and aches was not reported. This report was non-serious.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pain, Pyrexia
Clinical narrative: ACHES/PAIN; CHILLS; FEVER; HAMMER-LIKE HEADACHE; This spontaneous report received from a patient concerned a 53 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 17:00 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced aches/pain. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced fever. On 10-APR-2021, the subject experienced hammer-like headache. Laboratory data included: Body temperature (NR: not provided) 99 - 102 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovering from chills, fever, and hammer-like headache, and had not recovered from aches/pain. This report was non-serious.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Influenza like illness, Pain, Pain in extremity
Clinical narrative: BODY ACHES; TOOTH PAIN; CHILLS; SORE ARM; HEADACHE; FLU LIKE SYMPTOMS; This spontaneous report received from a patient concerned a 34 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805020 expiry: 25-MAY-2021) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced flu like symptoms. On 15-MAR-2021, the subject experienced body aches. On 15-MAR-2021, the subject experienced tooth pain. On 15-MAR-2021, the subject experienced chills. On 15-MAR-2021, the subject experienced sore arm. On 15-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, tooth pain, chills, sore arm, and headache on 18-MAR-2021, and the outcome of flu like symptoms was not reported. This report was non-serious.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Toothache
Clinical narrative: BODY ACHES; TOOTH PAIN; CHILLS; SORE ARM; HEADACHE; FLU LIKE SYMPTOMS; This spontaneous report received from a patient concerned a 34 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805020 expiry: 25-MAY-2021) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced flu like symptoms. On 15-MAR-2021, the subject experienced body aches. On 15-MAR-2021, the subject experienced tooth pain. On 15-MAR-2021, the subject experienced chills. On 15-MAR-2021, the subject experienced sore arm. On 15-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, tooth pain, chills, sore arm, and headache on 18-MAR-2021, and the outcome of flu like symptoms was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Pain, Pyrexia
Clinical narrative: DIARRHEA; VOMITING; CHILLS; FEVER; SHAKING; EXCRUCIATING PAIN ON LEFT SHOULDER; ACHEY; PAIN IN JOINT; This spontaneous report received from a patient concerned a 64 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 16:00 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced shaking. On 10-APR-2021, the subject experienced excruciating pain on left shoulder. On 10-APR-2021, the subject experienced achey. On 10-APR-2021, the subject experienced pain in joint. On 10-APR-2021, the subject experienced fever. On 10-APR-2021 03:00, the subject experienced chills. On 12-APR-2021, the subject experienced diarrhea. On 12-APR-2021, the subject experienced vomiting. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from shaking, excruciating pain on left shoulder, chills, and fever on 11-APR-2021, was recovering from achey, and pain in joint, and the outcome of diarrhea and vomiting was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Tremor, Vomiting
Clinical narrative: DIARRHEA; VOMITING; CHILLS; FEVER; SHAKING; EXCRUCIATING PAIN ON LEFT SHOULDER; ACHEY; PAIN IN JOINT; This spontaneous report received from a patient concerned a 64 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 16:00 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced shaking. On 10-APR-2021, the subject experienced excruciating pain on left shoulder. On 10-APR-2021, the subject experienced achey. On 10-APR-2021, the subject experienced pain in joint. On 10-APR-2021, the subject experienced fever. On 10-APR-2021 03:00, the subject experienced chills. On 12-APR-2021, the subject experienced diarrhea. On 12-APR-2021, the subject experienced vomiting. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from shaking, excruciating pain on left shoulder, chills, and fever on 11-APR-2021, was recovering from achey, and pain in joint, and the outcome of diarrhea and vomiting was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Ear swelling
Clinical narrative: EAR DOUBLED IN SIZE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced ear doubled in size. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of ear doubled in size was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: ARM HURT; HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN, expiry: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced arm hurt, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from arm hurt, and headache on APR-2021. This report was non-serious.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse drug reaction, Dizziness, Feeling hot
Clinical narrative: DIZZINESS; WARMTH; SIDE-EFFECTS; This spontaneous report received from a patient concerned a 25 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN, expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 09-APR-2021, the subject experienced side-effects. On 11-APR-2021, the subject experienced dizziness. On 11-APR-2021, the subject experienced warmth. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from side-effects on 10-APR-2021, had not recovered from dizziness, and the outcome of warmth was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: VERY ITCHY RASH; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. The batch number was not reported. As per procedure no follow-up will be requested for this case. No concomitant medications were reported. On APR-2021, the subject experienced very itchy rash. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of very itchy rash was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dizziness, Fatigue, Pain
Clinical narrative: LIGHT HEADED; LITTLE WEAK; FEVER; CHILLS; TIRED FATIGUED FEELING; BODY ACHES; This spontaneous report received from a patient concerned a 66 year old male. The patient's height, and weight were not reported. The patient's past medical history included covid. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978 expiry: UNKNOWN) dose was not reported, administered on 30-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, Laboratory data included: COVID-19 virus test (NR: not provided) Negative. On 09-APR-2021, the subject experienced body aches. On 09-APR-2021, the subject experienced tired fatigued feeling. On 09-APR-2021 03:00, the subject experienced chills. On 09-APR-2021 03:00, the subject experienced fever. On 12-APR-2021, the subject experienced light headed. On 12-APR-2021, the subject experienced little weak. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, chills, and fever on 11-APR-2021, was recovering from tired fatigued feeling, and the outcome of little weak and light headed was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: LIGHT HEADED; LITTLE WEAK; FEVER; CHILLS; TIRED FATIGUED FEELING; BODY ACHES; This spontaneous report received from a patient concerned a 66 year old male. The patient's height, and weight were not reported. The patient's past medical history included covid. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978 expiry: UNKNOWN) dose was not reported, administered on 30-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, Laboratory data included: COVID-19 virus test (NR: not provided) Negative. On 09-APR-2021, the subject experienced body aches. On 09-APR-2021, the subject experienced tired fatigued feeling. On 09-APR-2021 03:00, the subject experienced chills. On 09-APR-2021 03:00, the subject experienced fever. On 12-APR-2021, the subject experienced light headed. On 12-APR-2021, the subject experienced little weak. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, chills, and fever on 11-APR-2021, was recovering from tired fatigued feeling, and the outcome of little weak and light headed was not reported. This report was non-serious.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Nausea
Clinical narrative: DIZZY; NAUSEOUS FEELING; FATIGUE; This spontaneous report received from a patient concerned a 46 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On APR-2021, the subject experienced dizzy. On APR-2021, the subject experienced nauseous feeling. On APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from nauseous feeling, dizzy, and fatigue. This report was non-serious.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Headache, Pain, Pain in extremity
Clinical narrative: BODY ACHES; HARD SPOT; ARM REDNESS; SORE/PAIN  ARM; FEVER; HEADACHE; FATIGUE; This spontaneous report received from a consumer concerned a 50 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 2021421A expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced body aches. On 10-APR-2021, the subject experienced hard spot. On 10-APR-2021, the subject experienced arm redness. On 10-APR-2021, the subject experienced sore/pain arm. On 10-APR-2021, the subject experienced fever. On 10-APR-2021, the subject experienced headache. On 10-APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, fever, and headache on 11-APR-2021, and had not recovered from sore/pain arm, arm redness, fatigue, and hard spot. This report was non-serious.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Skin disorder
Clinical narrative: BODY ACHES; HARD SPOT; ARM REDNESS; SORE/PAIN  ARM; FEVER; HEADACHE; FATIGUE; This spontaneous report received from a consumer concerned a 50 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 2021421A expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced body aches. On 10-APR-2021, the subject experienced hard spot. On 10-APR-2021, the subject experienced arm redness. On 10-APR-2021, the subject experienced sore/pain arm. On 10-APR-2021, the subject experienced fever. On 10-APR-2021, the subject experienced headache. On 10-APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, fever, and headache on 11-APR-2021, and had not recovered from sore/pain arm, arm redness, fatigue, and hard spot. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Asthenia, Body temperature, Diarrhoea, Dizziness
Clinical narrative: WEAKNESS; FATIGUE; MUSCLE CRAMPS ON LEFT AND  RIGHT SIDE LOWER BACK; MUSCLE ACHES ON LEFT AND  RIGHT SIDE LOWER BACK/MUSCLE PAIN; DIARRHEA; LOST TASTE BUDS; DIZZINESS; HIGH FEVER; PAIN AT INJECTION SITE; BURNING AT INJECTION SITE; SWELLING AT INJECTION SITE; HEADACHE/ HEAD HURTING; This spontaneous report received from a patient concerned a 41 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included sinus issues, and other pre-existing medical conditions included the patient is unaware of any known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, and expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 10:45:00 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced dizziness. On 08-APR-2021, the subject experienced high fever. On 08-APR-2021, the subject experienced headache/ head hurting. On 08-APR-2021, the subject experienced pain at injection site. On 08-APR-2021, the subject experienced burning at injection site. On 08-APR-2021, the subject experienced swelling at injection site. Laboratory data included: Body temperature (NR: not provided) 98.9 F. On 10-APR-2021, the subject experienced diarrhea. On 10-APR-2021, the subject experienced lost taste buds. On 11-APR-2021, the subject experienced muscle cramps on left and right side lower back. On 11-APR-2021, the subject experienced muscle aches on left and right side lower back/muscle pain. On an unspecified date, the subject experienced weakness, and fatigue. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lost taste buds on 10-APR-2021, and high fever, and headache/ head hurting on 09-APR-2021, and the outcome of muscle aches on left and right side lower back/muscle pain, diarrhea, dizziness, fatigue, weakness, muscle cramps on left and right side lower back, pain at injection site, burning at injection site and swelling at injection site was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site pain, Injection site swelling, Muscle spasms
Clinical narrative: WEAKNESS; FATIGUE; MUSCLE CRAMPS ON LEFT AND  RIGHT SIDE LOWER BACK; MUSCLE ACHES ON LEFT AND  RIGHT SIDE LOWER BACK/MUSCLE PAIN; DIARRHEA; LOST TASTE BUDS; DIZZINESS; HIGH FEVER; PAIN AT INJECTION SITE; BURNING AT INJECTION SITE; SWELLING AT INJECTION SITE; HEADACHE/ HEAD HURTING; This spontaneous report received from a patient concerned a 41 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included sinus issues, and other pre-existing medical conditions included the patient is unaware of any known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, and expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 10:45:00 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced dizziness. On 08-APR-2021, the subject experienced high fever. On 08-APR-2021, the subject experienced headache/ head hurting. On 08-APR-2021, the subject experienced pain at injection site. On 08-APR-2021, the subject experienced burning at injection site. On 08-APR-2021, the subject experienced swelling at injection site. Laboratory data included: Body temperature (NR: not provided) 98.9 F. On 10-APR-2021, the subject experienced diarrhea. On 10-APR-2021, the subject experienced lost taste buds. On 11-APR-2021, the subject experienced muscle cramps on left and right side lower back. On 11-APR-2021, the subject experienced muscle aches on left and right side lower back/muscle pain. On an unspecified date, the subject experienced weakness, and fatigue. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lost taste buds on 10-APR-2021, and high fever, and headache/ head hurting on 09-APR-2021, and the outcome of muscle aches on left and right side lower back/muscle pain, diarrhea, dizziness, fatigue, weakness, muscle cramps on left and right side lower back, pain at injection site, burning at injection site and swelling at injection site was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: WEAKNESS; FATIGUE; MUSCLE CRAMPS ON LEFT AND  RIGHT SIDE LOWER BACK; MUSCLE ACHES ON LEFT AND  RIGHT SIDE LOWER BACK/MUSCLE PAIN; DIARRHEA; LOST TASTE BUDS; DIZZINESS; HIGH FEVER; PAIN AT INJECTION SITE; BURNING AT INJECTION SITE; SWELLING AT INJECTION SITE; HEADACHE/ HEAD HURTING; This spontaneous report received from a patient concerned a 41 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included sinus issues, and other pre-existing medical conditions included the patient is unaware of any known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, and expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 10:45:00 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced dizziness. On 08-APR-2021, the subject experienced high fever. On 08-APR-2021, the subject experienced headache/ head hurting. On 08-APR-2021, the subject experienced pain at injection site. On 08-APR-2021, the subject experienced burning at injection site. On 08-APR-2021, the subject experienced swelling at injection site. Laboratory data included: Body temperature (NR: not provided) 98.9 F. On 10-APR-2021, the subject experienced diarrhea. On 10-APR-2021, the subject experienced lost taste buds. On 11-APR-2021, the subject experienced muscle cramps on left and right side lower back. On 11-APR-2021, the subject experienced muscle aches on left and right side lower back/muscle pain. On an unspecified date, the subject experienced weakness, and fatigue. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lost taste buds on 10-APR-2021, and high fever, and headache/ head hurting on 09-APR-2021, and the outcome of muscle aches on left and right side lower back/muscle pain, diarrhea, dizziness, fatigue, weakness, muscle cramps on left and right side lower back, pain at injection site, burning at injection site and swelling at injection site was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Hypokinesia, Insomnia, Pain, Pyrexia
Clinical narrative: BODY ACHES; CAN BARELY MOVE; BARELY SLEPT; FEVER; HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. As per procedure no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the subject experienced body aches, can barely move, barely slept, fever, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the body aches, fever, headache, can barely move and barely slept was not reported. This report was non-serious.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain, Pyrexia, Restlessness
Clinical narrative: RESTLESSNESS; FEVER; ACHY THROUGHOUT THE BODY; HEADACHE; FATIGUE; This spontaneous report received from a consumer concerned a 52 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included pre-diabetic, hypertensive, and rheumatoid arthritis, and other pre-existing medical conditions included the patient had no known allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978 expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced achy throughout the body. On 09-APR-2021, the subject experienced headache. On 09-APR-2021, the subject experienced fatigue. On 10-APR-2021, the subject experienced restlessness. On 10-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from restlessness on 10-APR-2021, and fever on 12-APR-2021, was recovering from headache, and had not recovered from fatigue, and achy throughout the body. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: ADMINISTERED VACCINE HELD IN REFRIGERATOR FOR MORE THAN 6 HOURS; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 09-APR-2021, the subject experienced administered vaccine held in refrigerator for more than 6 hours. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administered vaccine held in refrigerator for more than 6 hours was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Pyrexia
Clinical narrative: FEVER; HEADACHE; TIRED; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included hypothermia, and concurrent conditions included penicillin allergy. The patient experienced drug allergy when treated with azithromycin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced fever. On APR-2021, the subject experienced headache. On APR-2021, the subject experienced tired. Laboratory data included: Body temperature (NR: not provided) 102 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, and headache, and the outcome of tired was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Erythema, Headache, Myalgia
Clinical narrative: SKIN REDNESS; VOMITING; JOINT PAIN; CHILLS; MUSCLE PAIN; NAUSEA; HEADACHE; This spontaneous report received from a patient concerned an 57 year old female. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection, and concurrent conditions included pleurisy, fibromyalgia, and worsened asthma. The patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 09:45 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced skin redness. On APR-2021, the subject experienced vomiting. On APR-2021, the subject experienced joint pain. On APR-2021, the subject experienced chills. On APR-2021, the subject experienced muscle pain. On APR-2021, the subject experienced nausea. On APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the nausea, muscle pain, joint pain, vomiting, chills, headache and skin redness was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: SKIN REDNESS; VOMITING; JOINT PAIN; CHILLS; MUSCLE PAIN; NAUSEA; HEADACHE; This spontaneous report received from a patient concerned an 57 year old female. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection, and concurrent conditions included pleurisy, fibromyalgia, and worsened asthma. The patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 09:45 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced skin redness. On APR-2021, the subject experienced vomiting. On APR-2021, the subject experienced joint pain. On APR-2021, the subject experienced chills. On APR-2021, the subject experienced muscle pain. On APR-2021, the subject experienced nausea. On APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the nausea, muscle pain, joint pain, vomiting, chills, headache and skin redness was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. As per procedure no follow-up will be requested for  this case. No concomitant medications were reported. On 2021, the subject experienced slept for 12 hours afterwards felt wiped out. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of slept for 12 hours afterwards felt wiped out was not reported. This report was non-serious.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Injection site pain, Myalgia
Clinical narrative: CHILLS; FEVER; HEADACHE; MUSCLE ACHES; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a 48 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 15:20 for prophylactic vaccination. No concomitant medications were reported. On 11-APR-2021, the subject experienced injection site arm pain. On 12-APR-2021, the subject experienced chills. On 12-APR-2021, the subject experienced fever. On 12-APR-2021, the subject experienced headache. On 12-APR-2021, the subject experienced muscle aches. Laboratory data included: Body temperature (NR: not provided) 101 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, chills, headache, muscle aches, and injection site arm pain. This report was non-serious.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: CHILLS; FEVER; HEADACHE; MUSCLE ACHES; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a 48 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 15:20 for prophylactic vaccination. No concomitant medications were reported. On 11-APR-2021, the subject experienced injection site arm pain. On 12-APR-2021, the subject experienced chills. On 12-APR-2021, the subject experienced fever. On 12-APR-2021, the subject experienced headache. On 12-APR-2021, the subject experienced muscle aches. Laboratory data included: Body temperature (NR: not provided) 101 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, chills, headache, muscle aches, and injection site arm pain. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hypoaesthesia
Clinical narrative: HEADACHES; FATIGUE; NUMBNESS IN ARM; NUMBNESS IN LEG; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On APR-2021, the subject experienced numbness in arm. On APR-2021, the subject experienced numbness in leg. On 10-APR-2021, the subject experienced fatigue. On 11-APR-2021, the subject experienced headaches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fatigue, and had not recovered from headaches, numbness in arm, and numbness in leg. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Contusion, Hyperhidrosis, Pyrexia, Rash pruritic
Clinical narrative: RASH AND ITCHING ALL OVER ARMS AND SPREAD OVER CHEST; FEELING HOT AND NIGHT SWEATS; ARM SWELLING; ARM BRUISING; FEVER; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: unknown) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 12-APR-2021, the subject experienced rash and itching all over arms and spread over chest. On 12-APR-2021, the subject experienced feeling hot and night sweats. On 12-APR-2021, the subject experienced arm swelling. On 12-APR-2021, the subject experienced arm bruising. On 12-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 101 F. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, arm swelling, rash and itching all over arms and spread over chest, feeling hot and night sweats, and arm bruising. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: RASH AND ITCHING ALL OVER ARMS AND SPREAD OVER CHEST; FEELING HOT AND NIGHT SWEATS; ARM SWELLING; ARM BRUISING; FEVER; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: unknown) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 12-APR-2021, the subject experienced rash and itching all over arms and spread over chest. On 12-APR-2021, the subject experienced feeling hot and night sweats. On 12-APR-2021, the subject experienced arm swelling. On 12-APR-2021, the subject experienced arm bruising. On 12-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 101 F. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, arm swelling, rash and itching all over arms and spread over chest, feeling hot and night sweats, and arm bruising. This report was non-serious.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Arthralgia, Diarrhoea, Fatigue, Headache
Clinical narrative: TINGLING IN THE FEET AND FINGERS; LEFT SIDE SENSITIVE TO TOUCH; CRAMPING IN THE ABDOMEN; DIARRHEA; FREQUENT URINATION; ACHY JOINTS; SORE MUSCLES; HEADACHE; NAUSEA; FATIGUE; This spontaneous report received from a patient concerned a 50 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included pollen allergy, dust mite allergy, and intravenous pyelogram dye allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1808978 expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 11:15 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced tingling in the feet and fingers. On 09-APR-2021, the subject experienced left side sensitive to touch. On 09-APR-2021, the subject experienced cramping in the abdomen. On 09-APR-2021, the subject experienced diarrhea. On 09-APR-2021, the subject experienced frequent urination. On 09-APR-2021, the subject experienced achy joints. On 09-APR-2021, the subject experienced sore muscles. On 09-APR-2021, the subject experienced headache. On 09-APR-2021, the subject experienced nausea. On 09-APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tingling in the feet and fingers, diarrhea, and nausea on 09-APR-2021, and left side sensitive to touch on 10-APR-2021, was recovering from headache, and had not recovered from fatigue, cramping in the abdomen, frequent urination, sore muscles, and achy joints. This report was non-serious.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperaesthesia, Myalgia, Nausea, Paraesthesia, Pollakiuria
Clinical narrative: TINGLING IN THE FEET AND FINGERS; LEFT SIDE SENSITIVE TO TOUCH; CRAMPING IN THE ABDOMEN; DIARRHEA; FREQUENT URINATION; ACHY JOINTS; SORE MUSCLES; HEADACHE; NAUSEA; FATIGUE; This spontaneous report received from a patient concerned a 50 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included pollen allergy, dust mite allergy, and intravenous pyelogram dye allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1808978 expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 11:15 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced tingling in the feet and fingers. On 09-APR-2021, the subject experienced left side sensitive to touch. On 09-APR-2021, the subject experienced cramping in the abdomen. On 09-APR-2021, the subject experienced diarrhea. On 09-APR-2021, the subject experienced frequent urination. On 09-APR-2021, the subject experienced achy joints. On 09-APR-2021, the subject experienced sore muscles. On 09-APR-2021, the subject experienced headache. On 09-APR-2021, the subject experienced nausea. On 09-APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tingling in the feet and fingers, diarrhea, and nausea on 09-APR-2021, and left side sensitive to touch on 10-APR-2021, was recovering from headache, and had not recovered from fatigue, cramping in the abdomen, frequent urination, sore muscles, and achy joints. This report was non-serious.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Injection site pain, Myalgia, Pyrexia
Clinical narrative: MUSCLE ACHES  (LOWER BACK); TENSION HEADACHE; CHILLS; FEVER; PAIN IN THE RIGHT ARM; This spontaneous report received from a patient concerned a 34 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no known allergies and comorbidities.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced chills. On 08-APR-2021, the subject experienced fever. On 08-APR-2021, the subject experienced pain in the right arm. Laboratory data included: Body temperature (NR: not provided) 101 F. On 10-APR-2021, the subject experienced muscle aches (lower back). On 10-APR-2021, the subject experienced tension headache. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, fever, pain in the right arm, muscle aches (lower back), and tension headache on 11-APR-2021. This report was non-serious.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Tension headache
Clinical narrative: MUSCLE ACHES  (LOWER BACK); TENSION HEADACHE; CHILLS; FEVER; PAIN IN THE RIGHT ARM; This spontaneous report received from a patient concerned a 34 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no known allergies and comorbidities.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced chills. On 08-APR-2021, the subject experienced fever. On 08-APR-2021, the subject experienced pain in the right arm. Laboratory data included: Body temperature (NR: not provided) 101 F. On 10-APR-2021, the subject experienced muscle aches (lower back). On 10-APR-2021, the subject experienced tension headache. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, fever, pain in the right arm, muscle aches (lower back), and tension headache on 11-APR-2021. This report was non-serious.